Market Cap (In USD)
3.31 Million
Revenue (In USD)
-
Net Income (In USD)
-17.29 Thousand
Avg. Volume
1.14 Million
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.304-2.92
- PE
- -
- EPS
- -
- Beta Value
- 0.469
- ISIN
- US29405E2081
- CUSIP
- 29405E208
- CIK
- 890821
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Joseph Edward Tucker Ph.D.
- Employee Count
- -
- Website
- https://www.enveric.com
- Ipo Date
- 2015-05-04
- Details
- Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.
More Stocks
-
SLROF
-
AFFORDABLEAffordable Robotic & Automatio
AFFORDABLE
-
RAINBOWFRainbow Foundations Limited
RAINBOWF
-
HG
-
XROXero Limited
XRO
-
CPAUCopAur Minerals Inc.
CPAU
-
DEEZRDeezer S.A.
DEEZR
-
SVRTSavorEat Ltd.
SVRT